Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ORCHID PHARMA ALKEM LABORATORIES/
ORCHID PHARMA
 
P/E (TTM) x 37.5 41.8 89.8% View Chart
P/BV x 6.5 7.7 84.8% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 ALKEM LABORATORIES   ORCHID PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
ORCHID PHARMA
Mar-23
ALKEM LABORATORIES/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs3,625439 826.7%   
Low Rs2,835273 1,038.1%   
Sales per share (Unadj.) Rs970.1163.1 594.7%  
Earnings per share (Unadj.) Rs84.213.5 622.1%  
Cash flow per share (Unadj.) Rs110.227.0 408.7%  
Dividends per share (Unadj.) Rs50.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs756.4168.7 448.4%  
Shares outstanding (eoy) m119.5740.82 292.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.32.2 152.7%   
Avg P/E ratio x38.426.3 145.9%  
P/CF ratio (eoy) x29.313.2 222.1%  
Price / Book Value ratio x4.32.1 202.5%  
Dividend payout %59.40-   
Avg Mkt Cap Rs m386,20714,522 2,659.4%   
No. of employees `000NANA-   
Total wages/salary Rs m21,314654 3,261.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,9936,659 1,741.9%  
Other income Rs m2,161194 1,112.0%   
Total revenues Rs m118,1536,853 1,724.0%   
Gross profit Rs m15,0651,235 1,219.8%  
Depreciation Rs m3,104548 566.6%   
Interest Rs m1,074329 326.3%   
Profit before tax Rs m13,048552 2,361.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9800-   
Profit after tax Rs m10,068552 1,822.4%  
Gross profit margin %13.018.5 70.0%  
Effective tax rate %22.80-   
Net profit margin %8.78.3 104.6%  
BALANCE SHEET DATA
Current assets Rs m86,0645,010 1,717.8%   
Current liabilities Rs m37,0713,719 996.8%   
Net working cap to sales %42.219.4 217.8%  
Current ratio x2.31.3 172.3%  
Inventory Days Days3357 56.8%  
Debtors Days Days671,180 5.7%  
Net fixed assets Rs m37,2457,242 514.3%   
Share capital Rs m239408 58.6%   
"Free" reserves Rs m90,2086,478 1,392.5%   
Net worth Rs m90,4476,886 1,313.4%   
Long term debt Rs m01,488 0.0%   
Total assets Rs m124,54112,252 1,016.5%  
Interest coverage x13.22.7 490.9%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.90.5 171.4%   
Return on assets %8.97.2 124.3%  
Return on equity %11.18.0 138.8%  
Return on capital %15.610.5 148.3%  
Exports to sales %14.681.9 17.8%   
Imports to sales %037.6 0.0%   
Exports (fob) Rs m16,9165,452 310.3%   
Imports (cif) Rs mNA2,501 0.0%   
Fx inflow Rs m16,9165,452 310.3%   
Fx outflow Rs m4,1902,726 153.7%   
Net fx Rs m12,7272,726 466.9%   
CASH FLOW
From Operations Rs m16,825183 9,174.9%  
From Investments Rs m1,128-312 -361.5%  
From Financial Activity Rs m-17,608312 -5,649.8%  
Net Cashflow Rs m416183 227.5%  

Share Holding

Indian Promoters % 56.7 69.8 81.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.4 18.6 130.9%  
FIIs % 8.5 4.1 205.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 30.2 143.4%  
Shareholders   65,184 36,931 176.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Orchid Pharma Share Price Performance

Period ALKEM LABORATORIES Orchid Pharma S&P BSE HEALTHCARE
1-Day -1.18% -0.40% 1.18%
1-Month -0.99% -14.06% -0.75%
1-Year 52.26% 173.54% 61.82%
3-Year CAGR 21.70% -23.64% 18.16%
5-Year CAGR 22.99% 184.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.